The global sales of single-use bioprocessing probes and sensors is estimated to be worth USD 3,051.6 million in 2024 and anticipated to reach a value of USD 5,362.7 million by 2034. Sales are projected to rise at a CAGR of 5.8% over the forecast period between 2024 and 2034. The revenue generated by single-use bioprocessing probes and sensors cover in 2023 was USD 2,884.3 million. The industry is anticipated to exhibit a Y-o-Y growth of 5.8% in 2024.
Probes and sensors, are designated for measuring critical parameters which include pH, dissolved oxygen, temperature, and conductivity during the manufacturing of biopharmaceuticals. These sensors are available in single-use forms and find many applications in the maintenance of sterile environments.
In the pharmaceutical industry, they are constituted in bioreactors and other bioprocessing equipment which are used for conducting the real-time process, such as cell cultures and fermentation. These disposable sensors save all of the cleaning and sterilization time between batches.
Their applications include cell culture monitoring, fermentation control, and assuring product quality in vaccines, monoclonal antibodies, and other biological production. Their ease of integration and compatibility with existing systems makes them valuable in research to large-scale production.
Global Single-use Bioprocessing Probes and Sensors Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 2,884.3 million |
| Estimated Size, 2024 | USD 3,051.6 million |
| Projected Size, 2034 | USD 5,362.7 million |
| Value-based CAGR (2024 to 2034) | 5.8% |
Single-use bioprocessing probes and sensors are majorly used for measuring critical parameters of the biopharmaceutical manufacturing. They have properties which eliminates cleaning and sterilization process. They significantly minimizes cross-contamination of pharmaceutical products during manufacturing process and ensures sterility.
This makes them highly suitable for applications in sterile environments, particularly in the manufacture of biologics, where product integrity is a matter of the utmost priority.
These sensors are highly important in the pharmaceutical field, where real-time monitoring of conditions in a bioreactor can make an optimal culture of cells, leading to a better product yield. Their application supports strict quality control measures in the manufacture of vaccines, monoclonal antibodies, and other biopharmaceutical products.
Their disposability means a lot when it comes to simplifying this compliance with regulatory requirements and improving process efficiency, reducing the risks for batch failure.
The single-use bioprocessing probes and sensors market is set to experience a significant growth of 5.8% during the forecast period. It is projected to create an incremental opportunity of USD 2,311.1 million and is predicted to rise 1.7 times the current market value through 2034.
Single-use bioprocessing sensors are of growing interest due to their flexibility, cost-effectiveness, and scalability. They allow for quick turnarounds between batches, accentuated in the value of multi-product facilities requiring frequent changeovers. In sensor technologies, recent developments have targeted improvements in precision, miniaturization, and integration with advanced data analytics and automation systems.
Innovations such as wireless communication capabilities and increased sensitivity for low-volume and high-density cultures further extend their range of applications; their utilization is becoming increasingly common in research and large-scale commercial production. This factors contribute to their strengthening market share in the biopharmaceutical manufacturing processes.
The table below provides a detailed comparison of the compound annual growth rate (CAGR) variations for the global single-use bioprocessing probes and sensors market, spanning from the base year (2023) to the current year (2024) over the first half of the year.
This analysis highlights significant shifts in market dynamics and identifies key trends in revenue generation, offering stakeholders crucial insights into the market's progression over the examined period. The first half (H1) includes January to June, while the second half (H2) comprises July to December.
The first half (H1) is the period from January to June, and the second half (H2) is July to December. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 7.1%, followed by a slightly lower growth rate of 6.5% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 7.1% (2023 to 2033) |
| H2 | 6.5% (2023 to 2033) |
| H1 | 5.8% (2024 to 2034) |
| H2 | 5.5% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 5.8% in the first half and remain relatively moderate at 5.5% in the second half. In the first half (H1) the market witnessed a decrease of -130 BPS while in the second half (H2), the market witnessed a decrease of -100 BPS.
Reduced Contamination Risk Associated with the Use of Single-use Bioprocessing Probes and Sensors Surges its Market Growth
The key factor for the growth and sale of single-use bioprocessing probes and sensors is the reduced risk of contamination in the pharmaceutical industry. These devices are pre-sterilized and intended for single use, thereby eliminating cross-contamination associated with reusable sensors.
This is an important stage during the manufacturing of biopharmaceuticals, when strict sterility is required to ensure product quality and patient safety. The elimination of contamination risks leads to fewer batch failures, consistent product quality-pretty critical to meet the strict regulatory standards driven by agencies such as FDA and EMA.
Helping manufacturers comply with such regulations, single-use sensors minimize the possibilities for costly product recalls, fines for non-compliance, and other regulatory repercussions.
These sensors also help in enhancing effectiveness in operations because they eliminate cleaning, sterilization, and recalibration processes essential in multi-use sensors. This reduces the downtime between production cycles, which implies that batch turnaround times can be shorter with lower operational costs.
All these gains in terms of efficiency make single-use sensors an effective choice of cost for pharmaceutical firms that have been trying to optimize their production and reduce costs.
Besides that, disposable sensors provide for faster time-to-market with new products. This is an essential component in the highly competitive area of biopharmaceuticals. Therefore, increased operational flexibility, the cost saved by the use of single-use bioprocessing probes are few of the factors combined in driving the wide adoption of single-use bioprocessing probes and sensors.
Faster Turnaround Time Achieved with the use of Single-use Bioprocessing Probes and Sensors propels its growth
Single-use bioprocessing probes and sensors have the added advantage of improving turnaround by being released from time-consuming sterilization processes and re-calibration. Being pre-sterilized and ready for immediate use, these single-use sensors avoid the labor-intensive process of sterilization that is commonly required for traditional reusable sensors.
With these steps avoided, the transition between batches of production is quick, which accelerates the overall manufacturing process of pharmaceuticals.
Biopharmaceutical manufacturing requires speed and efficiency in production to meet market demand, thus the faster turnaround time is of extreme relevance. These single-use sensors allow for quick setup and changeover so that switching between different production runs or products can be done much more easily.
This aids companies operating in multi-product facilities, such as vaccine production or responding to a surge in demand for a particular therapy.
Reduction in downtime translates to increased productivity and a better cost profile of the production process. Shortening the batches means more throughput, allowing pharmaceutical companies to produce more batches in a shortened time frame. These factors lead to substantial cost savings, higher revenues, and reduced time-to-market for new drugs and therapies.
Raising Environmental Concerns with the Disposable Nature of Single-use Sensors Hinders its Adoption Rate
Single-use bioprocessing sensors and probes are considered disposable in terms of current design, though it may be convenient for eliminating contamination risks and improving efficiency. Environmental concerns is limiting its efficient adoption in the pharmaceutical industry.
As, these typical single-use devices are made from plastic and other related synthetic materials, which leads to considerable waste. Their single-use leads to immense environmental effects as their use is great in large-scale manufacturing facilities where very large numbers of sensors are used.
Environmental sustainability is of significant concern for pharmaceutical companies due to mounting pressure from regulatory requirements. Using disposable single-use sensors goes against the goals of sustainability as disposal of these materials normally goes to landfill accumulation or incineration, causing bad environmental impacts from greenhouse gas emissions to possible leaching of chemicals into the soil and water.
Besides, the environmental footprint of such sensors may impact consumer and investor perceptions and, hence, the reputation and market position of the pharmaceutical companies.
These factors may impact the demand for these sensors as customers will have a preferential shift towards sustainable sensors. Therefore, the raising concerns to look for other alternatives of recycling programs may be related to cost and infrastructure.
The environmental impact thus associated with single-use sensors acts to constrain wide-scale adoption, making the industry balance the benefits of single-use technologies with sustainable practices.
Emphasis on Collaboration with Biopharmaceutical Companies Expanding their Production Capabilities
Emphasizing collaboration with biopharmaceutical companies can bring about tremendous growth in sales and market presence for those manufacturers involved in single-use bioprocessing probes and sensors. A manufacturer developing sensor solutions that meet specific needs related to unique operational conditions or stringent regulatory requirements.
This level of customization ultimately makes the sensors more appealing and accelerates their rate of adoption. Furthermore, collaboration makes the validation and integration process much easier because the manufacturers work directly with the clients to ensure that their sensors are pre-validated to meet the requirements for compatibility with systems already in existence.
Support of this nature cuts down on implementation time and cost, thereby accelerating the pace of single-use technology adoption.
Closeness to the biopharmaceutical companies makes the manufacturers preferred suppliers, and thus repeat business is considered, with insight into evolving market needs. Innovation is also fostered under such joint development projects.
Through feedback from biopharmaceutical companies, manufacturers have been able to create advanced sensors with new functionalities and improved performance. This innovation differentiates their products in the competitive market.
Successful collaborations also enhance the market visibility and credibility of the manufacturer. Endorsements and case studies from top-tier biopharmaceutical companies strengthen the marketing effort by building reputation and, therefore, attracting new clients.
The global single-use bioprocessing probes and sensors cover industry recorded a CAGR of 5.8% during the historical period between 2019 and 2023. The growth of the single-use bioprocessing probes and sensors cover industry was positive as it reached a value of USD 2,884.3 million in 2023 from 2,339.5 million in 2019.
Influential elements such as the reduced need for cleaning and sterilization of reusable sensors significantly contribute to the increased sales of single-use bioprocessing probes and sensors in the pharmaceutical industry.
These factors aided pharmaceutical companies in accomplishing product quality consistency while avoiding expensive batch failures. Adoption of these devices also aided the pharmaceutical industry to comply with the stringent regulatory standards of authorities.
Another critical reason for its increased adoption is its assistance in improving operational efficiency. Single-use sensors rationalize production by offering faster setup and changeovers between batches- major plus factors in multi-product facilities and in those where there are fast changes in production. This results in faster time-to-market and reduced operational costs.
Increasing demand for personalized medicine and the growing developments in the biopharmaceutical sector are a few of the factors that are providing future growth opportunities for the single-use bioprocessing probes and sensors market. Growing advancements in sensor technology which provides higher accuracy further surges its market growth.
Moreover, further enhanced innovations such as wireless integration, real-time monitoring of data, reduction in size, and automation of these products, its ability to control processes further surges its growth in the market.
In addition to this, rising CMOs, its emerging application in the cell and gene therapies provide good opportunities for growth from future prospects. Single-use sensors are highly adaptable and efficient to meet such emerging requirements as these therapies often call for highly specialized and flexible production processes.
Combination of these factors positions single-use bioprocessing probes and sensors for continued growth and expanded market adoption.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 15% to 20% in global market. These market leaders have manufacturing capacity, and wide of product portfolio in the market.
These market leaders differentiate themselves based on the technology, their extensive expertise in manufacturing and their geographical outreach reach in the market. These factors aid them in serving a wide range of consumer base. Prominent companies within tier 1 include Sartorius AG; Thermo Fisher Scientific; Danaher Corporation; PreSens Precision Sensing GmbH
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions with their high influence on the local market. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good technology but their presence is limited to certain markets. Prominent companies in tier 2 include ABEC; Hamilton Company; PendoTECH LLC; Equflow; Parker Hannifin Corporation; Malema Engineering Corporation
Tier 3 includes the majority of companies that have limited geographical outreach or are operating at the local presence and serving niche markets having revenue below USD 50 million. These companies are focused towards fulfilling the demand from local market and are therefore classified as the tier 3 share segment.
They are comparatively small-scale players which is generally recognized as an unorganized market. These players doesn’t have extensive infrastructure or higher production capabilities.
The section below covers the industry analysis for the single-use bioprocessing probes and sensors covering market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America and is projected to grow at a CAGR of 1.8% through 2034. In Asia Pacific, India is projected to witness a CAGR of 6.6% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Canada | 3.1% |
| Spain | 3.4% |
| France | 2.9% |
| South Korea | 4.6% |
| China | 5.8% |
| Australia | 2.7% |
Germany’s single-use bioprocessing probes and sensors cover market is poised to exhibit a CAGR of 1.8% between 2024 and 2034. Germany ranks among the major countries manufacturing and researching biopharmaceuticals.
Germany, being one of the leading competence centers for biotech innovation and production, demands more sophisticated technologies that ensure high productivity, quality of products, and compliance with regulatory requirements.
Single-use sensors meet these requirements because such sensors avoid all the risks of cross-contamination and reduce cumbersome cleaning and sterilization-essential in maintaining sterile conditions within biopharmaceutical production.
German biopharmaceutical research and manufacturing are benchmarks in excellence, with high levels of complication; hence, parameters like pH, dissolved oxygen, and temperature have to be measured reliably in real-time.
Single-use sensors can meet the high accuracy and ease of integration needed for accurate control and optimization of the bioprocess. The ability to set up a fast production process in biopharmaceutical manufacturing contributes to its market growth in the country.
Therefore, the growing emphasis of German biotech industry towards driving operational efficiencies by reducing waste contributes to the growth of the single-bioprocessing probes and sensors market.
North America, spearheaded by the USA currently holds majority of the share of the global single-use bioprocessing probes and sensors cover industry. The market in the USA is anticipated to grow at a CAGR of 1.8% throughout the forecast period 2034.
Enormous investments in biotechnology, personalized medicines, and cell and gene therapies within the USA drive sales of single-use bioprocessing probes and sensors by a huge margin. For such advanced therapies, production processes are usually complex, and highly specialized. Use of single-use bioprocessing probes provides added advantages which can be realized through its flexibility and efficiency.
Single-use sensors eliminate the cross-contamination risk, help in maintaining the sterile environment for the manufacturing of personalized medicine and cell therapy. Quick changeovers between batches, and products, enable fast and flexible manufacturing in this growing field.
This is matched by single-use sensors with their high degree of accuracy and real-time monitoring, very rigorous demands are put forward by the processes of biotechnology and gene therapy.
The investment in these industries propels the demand for more advanced and scalable manufacturing solutions, further reinforcing the adoption of single-use technologies. As the United States continues to be at the forefront in the development of biotech and personalized healthcare, it demands for efficient, flexible, and contamination-free bioprocessing tools, anticipating its growing demand and adding up to sales in the market.
Increased competition, innovation, and pricing pressure from new entrants lead to accelerating the rate of adoption of single-use technologies. With more advanced cost-effective solutions, companies are shifting away from traditional multiuse systems towards the latest, more flexible, efficient single-use options. This transition is most marked in China, which is experiencing a rapid growth of its biopharmaceutical sector.
In addition, most of the newer market players rely on exports as a way to access world markets, using China's manufacturing and cost advantages. Therefore, the growing supply of single-use bioprocessing probes to meet global demand enables such companies not only to develop their source of income but also to enter world markets, thus promoting further industry development.
The focus on export allows Chinese companies to scale up production, generate economies of scale, and invest more in R&D. This trend strengthens the local market and positions China as a critical node in the international single-use bioprocessing market, which is expected to contribute to the expansion of domestic and international markets.
The section contains information about the leading segments in the industry. By sensor type, the pH sensor segment is estimated to account for 22.5% of the market share and is anticipated to witness significant growth during the forecast period.
| Sensor Type | pH Sensor |
|---|---|
| Value Share (2024) | 22.5% |
The pH Sensor segment dominates the market in terms of revenue, accounting for almost 22.5% of the market share in 2024. The pH sensor segment dominates the single-use bioprocess detection sensor market due to its key role in ensuring optimal bioprocess conditions.
Accurate pH measurements are essential to monitor and control processes such as cell growth and inflammation, which directly affect product efficiency in the biopharmaceutical industry and are ideal for reliability and ease of integration into disposable systems.
They eliminate the need for extensive washing and disinfection, reducing operational complexity and costs. Thus, the combination of operational efficiencies, as well as cost-effectiveness, contributes to their widespread acceptance of these single-use bioprocessing probes in the pharmaceutical industry.
| Workflow | Upstream |
|---|---|
| Value Share (2024) | 82.7% |
The upstream segment dominates the market in terms of revenue, accounting for almost 82.7% of the market share in 2024. In single-use bioprocessing, the upstream phase mainly dominates operations due to its critical role in preliminary biomanufacturing.
Advantages of such single-use probes and sensors are that they bring in greater efficiency and flexibility into the upstream processes, including cell culture and fermentation. These systems give out real-time data on critical parameters like pH, temperature, and dissolved oxygen.
Besides being important for improvement and productivity, the risk of contamination is reduced in clusters. This reduction in impurities is critical for maintaining a high level of product quality and safety. Additionally, single-use technology provides cost savings by reducing operating costs associated with equipment maintenance and cleaning.
Collectively, these advantages make single-use probe sensors particularly useful for upstream bioprocessing, giving them a strong presence in the manufacturing phase of the pharmaceutical industry
Key players operating in the single-use bioprocessing probes and sensors cover market are investing in development of advanced and innovative products that are more reliable and efficient. Also, many of the key players are emphasizing on making strategic collaborations and acquisition for expansion of their geographical presence and strengthening their market share.
Recent Industry Developments in Single-use Bioprocessing Probes and Sensors Market
In terms of sensor type, the industry is divided into pH sensor, oxygen sensor, pressure sensors, temperature sensors, conductivity sensors, flow meters & sensors and other sensor types
In terms of workflow, the industry is divided into Upstream and downstream
In terms of end use, the industry is divided into biopharmaceutical manufacturer and labs & academic/ clinical research institutes
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA), have been covered in the report.
The global single-use bioprocessing probes and sensors cover industry is projected to witness CAGR of 5.8% between 2024 and 2034.
The global single-use bioprocessing probes and sensors cover industry stood at USD 2,884.3 million in 2023.
The global single-use bioprocessing probes and sensors cover industry is anticipated to reach USD 5,362.7 million by 2034 end.
India is set to record the highest CAGR of 6.6% in the assessment period.
The key players operating in the global single-use bioprocessing probes and sensors cover industry include Sartorius AG; Thermo Fisher Scientific; Danaher Corporation; PreSens Precision Sensing GmbH; ABEC; Hamilton Company; PendoTECH LLC; Equflow; Parker Hannifin Corporation; Malema Engineering Corporation; Dover Corporation; Broadley-James Corporation; High Purity New England, Inc.; Cole-Parmer Instrument Company, LLC.; ESI Ultrapure are few of the key players in the single-use bioprocessing pr
Explore Similar Insights
Single-use Bioprocessing Probes and Sensors Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
